These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000053-34 Comparison of continuous combined estrogen-progestin regimen in alleviation of estrogen deficiency symptoms of postmenopausal women. A randomized, double-blind, fixed dose, multicentre phase IIIb stu... 2005-11-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-000185-12 A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center study to evaluate the effect of Stalevo in patients with Parkinson's disease 2008-11-11 bad-data
Reported results 2004-001225-16 Survival of patients with acute heart failure in need of intravenous inotropic support; a multicentre parallel- group, randomised, double- blind, double- dummy study of levosimendan versus dobutamine ... 2005-08-11 due-trials
Not reported 2004-002643-27 Efficacy and tolerability of Comtess® versus Cabaseril® as add-on to levodopa in the treatment of Parkinsonian patients suffering from wearing- off phenomenon 2005-06-14 due-trials
Reported results 2004-004225-10 Effects of peroral levosimendan in the prevention of further hospitalisations in patients with chronic heart failure. A randomised, double-blind, placebo-controlled, multi-centre, parallel-group study 2006-03-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-005234-39 Multicentre, randomised, double-blind study to compare Stalevo® to levodopa/carbidopa in patients with Parkinson's disease experiencing symptoms of early wearing-off 2009-03-31 bad-data
Other 2005-002541-39 A Prospective, Multi-Centre, Randomised, Double-Blind Comparison of intravenous Dexmedetomidine with Propofol/Midazolam for continous sedation (24 hours to 14 days) of ventilated Patients in Intensive... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-001755-36 Efficacy and safety of Stalevo in subjects with early wearing-off identified using a screening tool WOQ-9; An open, non-randomised, multinational, multi-centre 6-week direct switch study in levodopa-t... 2007-08-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006030-17 A PROSPECTIVE, MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS DEXMEDETOMIDINE WITH PROPOFOL FOR CONTINUOUS SEDATION OF VENTILATED PATIENTS IN INTENSIVE CARE UNIT 2010-03-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006031-50 A PROSPECTIVE, MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS DEXMEDETOMIDINE WITH MIDAZOLAM FOR CONTINUOUS SEDATION OF VENTILATED PATIENTS IN INTENSIVE CARE UNIT 2009-10-07 bad-data
Reported results 2007-001676-36 Non-inferiority study; Comparison of polyethylene glycol solution with and without electrolytes for treatment of chronic constipation in elderly institutionalised patients: a double-blind, randomised,... 2007-07-01 due-trials
Reported results Terminated 2007-002496-14 Effects of single doses of Stalevo 200 and levodopa/carbidopa 200/50 mg on striatal 11C-raclopride binding potential in Parkinson’s disease patients with wearing-off symptoms. An open, randomised, act... 2008-03-27 due-trials
Reported results 2007-007197-31 EFFECTS OF ORAL LEVOSIMENDAN ON AMBULATORY ELECTROCARDIOGRAPHIC VARIABLES AND CEREBROVASCULAR REACTIVITY IN PATIENTS WITH RECENT STROKE OR TIA. A RANDOMISED, DOUBLE BLIND, PLACEBO-CONTROLLED, DOSE FIN... 2009-09-18 due-trials
Reported results 2010-022200-46 Efficacy and safety of ODM-101 compared to a standard combination (Stalevo®); a randomised, double-blind, crossover, proof of concept study in patients with Parkinson’s disease and end-of-dose motor f... 2012-08-07 due-trials
Exempt, with results 2010-022802-41 SAFETY AND PHARMACOKINETICS OF ODM-201 IN PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER: OPEN, NON-RANDOMISED, UNCONTROLLED, MULTICENTRE, MULTIPLE DOSE ESCALATION STUDY WITH A RANDOMISED PHASE II E... 2013-07-09 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-022803-24 SAFETY AND TOLERABILITY OF ODM-201 IN PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER: OPEN, NON-RANDOMISED, UNCONTROLLED, MULTICENTRE, EXTENSION STUDY TO STUDY 3104001 2015-10-21 bad-data
Reported results 2010-022915-21 Duration of motor response after administration of experimental levodopa/carbidopa/entacapone treatment regimens compared to standard treatment (Stalevo®); a randomised, double-blind, crossover, multi... 2011-07-25 due-trials
Ongoing, reported early 2010-022922-34 Safety and efficacy of ORM-12741 on cognitive and behavioural symptoms in patients with Alzheimer’s disease: A randomised, double-blind, placebo-controlled, parallel group, multicentre study of 12 wee... not-yet-due
Reported results Terminated 2010-024005-13 Efficacy of ORM-12741 for prevention of cold-induced vasospasm; a randomised, double-blind, placebo-controlled, single centre crossover study in patient with Raynaud's phenomenon secondary to systemic... 2011-12-14 due-trials
Completed, but no date, and reported results 2011-001490-40 Comparative evaluation of the effects of dexmedetomidine and propofol on patient/ventilator interaction in difficult-to-wean mechanically ventilated patients; a prospective, open, randomised, multic... bad-data
Reported results 2011-004496-37 A RANDOMISED, MULTICENTRE, TWO-ARM, PARALLEL GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE EFFICACY AND SAFETY CLINICAL STUDY OF IBUPROFEN 5% GEL IN ADULT HUMAN PATIENTS WITH PAIN RELATED TO UN... 2012-10-05 due-trials
Reported results 2011-004497-28 A RANDOMISED, MULTICENTRE, TWO-ARM, PARALLEL GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE EFFICACY AND SAFETY CLINICAL STUDY OF IBUPROFEN 5% ROLL-ON GEL IN ADULT HUMAN PATIENTS WITH PAIN RELAT... 2012-10-05 due-trials
Ongoing 2013-003820-36 A MULTINATIONAL, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-000217-30 EFFICACY OF ORM-12741 ON AGITATION/AGGRESSION SYMPTOMS IN PATIENTS WITH ALZHEIMER’S DISEASE: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTICENTRE STUDY OF 12 WEEKS 2017-10-09 bad-data
Reported results 2014-002705-38 STUDY COMPARING BRONCHODILATOR EFFICACY OF TWO DRY POWDER INHALERS, BUDESONIDE/FORMOTEROL EASYHALER AND SYMBICORT TURBUHALER; A RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, MULTICENTRE, SINGLE DOSE, CROSSO... 2015-06-12 due-trials
Exempt 2014-003642-26 SAFETY AND PHARMACOKINETICS OF ODM-204 IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): OPEN, NONRANDOMISED, UNCONTROLLED, MULTICENTRE, DOSE ESCALATION, FIRST-IN-MAN STUDY WITH... 2019-01-21 not-yet-due
Reported results 2014-004567-21 Effects of ODM-109 on respiratory function in patients with ALS. A randomised, double blind, placebo-controlled, cross-over, 3-period, multicentre study with open-label follow-up extension 2017-05-11 due-trials
Reported results 2015-004507-23 Efficacy and safety of ODM-104 compared to a standard combination (Stalevo); a randomised, double-blind, crossover proof-of-concept study in patients with Parkinson's disease and end-of-dose wearing-o... 2018-03-27 due-trials
Exempt 2015-004826-32 Safety and pharmacokinetics of ODM-207 in patients with selected advanced solid tumours: an open-label, non-randomised, uncontrolled, multicentre, first-in-human study with cohort expansion not-yet-due
Exempt 2017-002534-23 SAFETY AND PHARMACOKINETICS OF ODM-208 IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER not-yet-due
Ongoing 2017-002754-36 Effects of oral Levosimendan (ODM-109) on respiratory function in patients with ALS not-yet-due
Exempt 2018-002249-13 SAFETY AND PHARMACOKINETICS OF ODM-209 IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER OR ESTROGEN RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE ADVANCED BREAST... not-yet-due
Trial is outside EEC, and reported results 2018-003063-64 Open clinical trial to evaluate safety, tolerability, and efficacy of Dexdor for bad-data
Ongoing 2018-004180-31 Effects of oral Levosimendan (ODM-109) on respiratory function in patients with ALS: open label extension for patients completing study 3119002 not-yet-due